EVOFEM BIOSCIENCE INC (EVFM) earnings
EVFM earnings moved a median of +1.72% by the close. Quarterly and annual EVFM reports and results, each read against the price at its own news timestamp. Back to the EVFM overview →
14 measured EVFM earnings events.
Where these EVFM earnings landedvs 14 measured EVFM earnings reactions
| Middle 50% of EVFM earnings reactions | -2.34% to +6.22% |
|---|---|
| Median reaction (to close) | +1.72% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 EVFM earnings events with a measured close landed between -2.34% and +6.22%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Evofem Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Evofem Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | +0.00% | +0.00% | |
| Form 10-Q Evofem Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form 10-K Evofem Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.75% | |
| Form 10-Q Evofem Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +4.30% | |
| Evofem Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | +7.47% | |
| Form 10-Q Evofem Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +7.47% | |
| Form 10-K/A Evofem Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.04% | -10.20% | |
| Form 10-K Evofem Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | +14.94% | +3.45% | |
| Form 10-Q Evofem Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -23.08% | -24.61% | |
| Form 10-Q Evofem Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.06% | +6.38% | |
| Form 10-Q Evofem Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | -7.19% | -3.13% | |
| Form 10-K Evofem Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | -5.26% | +36.84% | |
| Form 10-Q Evofem Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | -12.50% | -12.50% |
Keep exploring
More EVFM: analyst actions → · SEC filings → · EVFM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PETLIFE PHARMS INC (PTLF) | 112 | 0.00% | 34% |
| Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO) | 112 | -0.05% | 43% |
| Synlogic, Inc. (SYBX) | 111 | +0.29% | 53% |
| Aptose Biosciences Inc (APS_TSE) | 110 | 0.00% | 23% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.